|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | |
| C07K 16/28 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 35/04 |
| (11) | Number of the document | 3489261 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18194705.2 |
| Date of filing the European patent application | 2013-03-15 | |
| (97) | Date of publication of the European application | 2019-05-29 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261693230 P | 2012-08-24 | US | |
| 201261709055 P | 2012-10-02 | US | |
| 201261709803 P | 2012-10-04 | US |
| (72) |
KIPPS, Thomas, James, US
YU, Jian, US
CUI, Bing, US
CHEN, Liguang, US
WIDHOPF, George, US
PRUSSAK, Charles, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
|
| (54) | ANTIBODIES AND VACCINES FOR USE IN TREATING ROR1 CANCERS AND INHIBITING METASTASIS |
| ANTIBODIES AND VACCINES FOR USE IN TREATING ROR1 CANCERS AND INHIBITING METASTASIS |